Evidence map›Paper›PMID 32339260›Full record

ReviewAnaesthesia2020

Patient blood management during the COVID-19 pandemic: a narrative review.

D M Baron, M Franchini, S M Goobie, M Javidroozi, A A Klein, S Lasocki, G M Liumbruno, M Muñoz, A Shander, D R Spahn and 2 more

Open access · hybridAbstract readReview
In one paragraph

Review in Anaesthesia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. [Appropriate use of blood components in the adult population].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 11 institutions in 8 countries.

D M BaronDepartment of Anaesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna, Austria.
M FranchiniDepartment of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, Italy.
S M GoobieDepartment of Anesthesiology, Critical Care and Pain Medicine, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
M JavidrooziDepartment of Anesthesiology and Critical Care Medicine, Englewood Hospital and Medical Center, New Jersey, NJ, USA.
A A KleinDepartment of Anaesthesia and Intensive Care, Royal Papworth Hospital, Cambridge, UK.
S LasockiDépartement Anesthésie Réanimation, CHU Angers, Université d'Angers, France.
G M LiumbrunoItalian National Blood Centre, Rome, Italy.
M MuñozPeri-operative Transfusion Medicine, Department of Surgical Specialties, Biochemistry and Immunology, School of Medicine, University of Málaga, Spain.
A ShanderDepartment of Anesthesiology, Critical Care and Hyperbaric Medicine, Englewood Health, NJ, USA.
D R SpahnInstitute of Anesthesiology and Head Anesthesiology, Intensive Care Medicine and OR Facilities, University of Zurich and University Hospital Zurich, Switzerland.
K ZacharowskiDepartment of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
P MeybohmDepartment of Anesthesiology, University Hospital Würzburg, Germany.
Azienda Ospedaliera Carlo Poma · ITEnglewood Hospital and Medical Center · USHarvard University · USMedical University of Vienna · ATPapworth Hospital · GBSanta Fe College · USUniversidad de Málaga · ESUniversitätsklinikum Würzburg · DEUniversité d'Angers · FRUniversity Hospital Frankfurt · DEUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As COVID-19 disease escalates globally, optimising patient outcome during this catastrophic healthcare crisis is the number one priority. The principles of patient blood management are fundamental strategies to improve patient outcomes and should be given high priority in this crisis situation. The aim of this expert review is to provide clinicians and healthcare authorities with information regarding how to apply established principles of patient blood management during the COVID-19 pandemic. In particular, this review considers the impact of the COVID-19 pandemic on blood supply and specifies important aspects of donor management. We discuss how preventative and control measures implemented during the COVID-19 crisis could affect the prevalence of anaemia, and highlight issues regarding the diagnosis and treatment of anaemia in patients requiring elective or emergency surgery. In addition, we review aspects related to patient blood management of critically ill patients with known or suspected COVID-19, and discuss important alterations of the coagulation system in patients hospitalised due to COVID-19. Finally, we address special considerations pertaining to supply-demand and cost-benefit issues of patient blood management during the COVID-19 pandemic.

Indexed as

BetacoronavirusAnemiaBlood Coagulation DisordersBlood DonorsCoronavirus InfectionsCOVID-19Elective Surgical ProceduresEmergenciesHumansOperative Blood SalvagePandemicsPneumonia, ViralPreoperative CareSARS-CoV-2anaemiacoagulationcoronavirusCOVID-19patient blood management

Identifiers

PMID32339260
PMCPMC7497056
OpenAlexW3020528881

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.